Home
Treat to Target in Rheumatic Diseases: Rationale and Results
Loading Inventory...
Barnes and Noble
Treat to Target in Rheumatic Diseases: Rationale and Results
Current price: $128.99


Barnes and Noble
Treat to Target in Rheumatic Diseases: Rationale and Results
Current price: $128.99
Loading Inventory...
Size: OS
*Product Information may vary - to confirm product availability, pricing, and additional information please contact Barnes and Noble
Guest edited by Dr. Daniel Aletaha, this issue of Rheumatic Disease Clinics will cover “Treat to Target in Rheumatic Diseases with a focus on rationale and results. This issue is one of four selected each year by our series Consulting Editor, Dr. Michael Weisman. Articles explore diseases, including, but not limited to: History, Rheumatoid Arthritis, Psoriatic Arthritis, Spondylarthropathies, Systemic lupus erythematosus, PMR and GCA, Inflammatory Myopathies (PM/DM), Gout, and Subclinical Targets.